- Posted Monday May 5, 2014
TGen Dr. Bodour Salhia named to 2014 Class of 40 Under 40
Newspaper recognizes TGen cancer researcher among Phoenix's brightest young leaders
PHOENIX, Ariz. - May 5, 2014 - Dr. Bodour
Salhia, a cancer researcher at the Translational Genomics Research
Institute (TGen), has been named one of the Phoenix
Business Journal's 2014 Class of 40 Under 40.
Dr. Salhia, an Assistant Professor in TGen's Integrated Cancer Genomics Division, will be among the 40 up-and-coming Phoenix leaders - less than 40 years of age - at an awards reception June 19 at Phoenix Theater.
In his award notification letter to Dr. Salhia, PBJ Publisher Don Henninger said, "I speak for all the judges in saying that we feel honored to have seen a glimpse of your life and career. You are most certainly a valuable member of our community and a source of inspiration for all."
All 40 Under 40 classmates will be featured in a special section of the June 20 edition of the PBJ.
"Bodour is a gem; brilliant and transparent. She is an incredible asset to TGen and to the state of Arizona. Watching her growth and career ascent has been one of the highlights of my entire career," said Dr. John Carpten, TGen Deputy Director of Basic Science.
"She is an amazing scientist, but also frequently participates in patient advocacy and community education," said Dr. Carpten, also Professor and Director of TGen's Integrated Cancer Genomics Division. "We are so proud of Bodour. To me, this is not simply a recognition of her achievements, but also a reward for all that she does for others."
Dr. Salhia, who specializes in researching breast cancer and multiple myeloma, is the fourth TGen staff member in three years to be selected to PBJ's 40 Under 40. Dr. Matt Huentelman, an Associate Professor in TGen's Neurogenomics Division, and Dr. Glen Weiss, a Clinical Associate Professor in TGen's Cancer and Cell Biology Division, were named in 2013. Dr. Candice Nulsen, TGen's former Director of Education and Community Outreach, was selected in 2012.
"I am so thankful and humbled to be selected among this year's 40 Under 40 by the Phoenix Business Journal," said Dr. Salhia, whose community work has included outreach to cancer patients of the Navajo Nation, and service as a board member of Susan G. Komen for the Cure, Central and Northern Arizona Affiliate. "This award is not just about me, but also reflects all the cutting-edge research that TGen conducts, using the human genome to devise better treatments for patients today."
The 40 Under 40 program's hundreds of alumni includes Phoenix Mayor Greg Stanton, a member of the TGen Board of Directors, and Arizona Diamondbacks President Derrick Hall, a member of TGen's National Advisory Council for Pancreatic Cancer Research.
# # #
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with cancer, neurological disorders and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit:www.tgen.org.
TGen Senior Science Writer